Left Atrial Appendage Shape Linked to Stroke Risk in AF Left Atrial Appendage Shape Linked to Stroke Risk in AF
With names like cauliflower and chicken wing, one type of LAA was associated with a more than 2.5-fold higher risk of stroke or transient ischemic attack while another with a 68% decreased risk.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 23, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

CT angio offers late thrombectomy option to stroke patients
By showing a strong link between ischemic core growth and blood flow in th...Read more on AuntMinnie.comRelated Reading: Mobile stroke units with onboard CT deliver best early care Use of CTA, CT perfusion up -- but for the right reasons CTA lowers costs, improves outcomes for minor stroke CT matches MRI for late-window stroke evaluation Study reveals steep cost of delaying stroke treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 2, 2021 Category: Radiology Source Type: news

The Long-term Risk for MI or Stroke After PPI Therapy The Long-term Risk for MI or Stroke After PPI Therapy
Some studies have suggested that PPI use increases long-term cardiovascular risk, but this analysis found no increased risk of MI or ischemic stroke in the first decade after PPI therapy.Alimentary Pharmacology & Therapeutics (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 27, 2021 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news

Antithrombotic Therapy Fails to Prevent Stroke in COVID-19 Antithrombotic Therapy Fails to Prevent Stroke in COVID-19
Anticoagulant and/or antiplatelet therapy with a variety of agents does not prevent acute ischemic stroke in elderly patients with COVID-19 and comorbidities, new research suggests.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 21, 2021 Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news

Sleep Apnea Linked to Lower Stroke Mortality After Thrombectomy Sleep Apnea Linked to Lower Stroke Mortality After Thrombectomy
Obstructive sleep apnea is paradoxically associated with lower risk for mortality and in-hospital complications after thrombectomy for acute ischemic stroke, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 21, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Saccular Aneurysm No Bar to Thrombolysis in Ischemic Stroke Saccular Aneurysm No Bar to Thrombolysis in Ischemic Stroke
Thrombolysis appears to be relatively safe in stroke patients with saccular unruptured intracranial aneurysms but may increase risk for rupture in those with large fusiform aneurysms.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 8, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Stroke: The signs in the eyes that could foreshadow an acute incident
STROKE is one of the leading causes of death and disability worldwide, but not all incidents are characterised by overt symptoms. A transient ischaemic attack - or mini stroke - will often be brushed off as a minor mishap. These transient symptoms, however, often signal a subsequent fatal or disabling stroke. Four signs in the eyes could signal an undetected mini-stroke, according to Doctor Clare O'Donnell. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2021 Category: Consumer Health News Source Type: news

Ticagrelor of Net Clinical Benefit aAfter Stroke, TIA: THALES Ticagrelor of Net Clinical Benefit aAfter Stroke, TIA: THALES
A new analysis of data from the THALES trial separates out the reduction in ischemic events from the increase in bleeding events and shows the benefit outweighs the risk in a ratio of four-to-one.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 18, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

Ticagrelor of Net Clinical Benefit After Stroke, TIA: THALES Ticagrelor of Net Clinical Benefit After Stroke, TIA: THALES
A new analysis of data from the THALES trial separates out the reduction in ischemic events from the increase in bleeding events and shows the benefit outweighs the risk in a ratio of four-to-one.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 17, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Aspirin and Heparin Increase Bleeding Risk During EVT Aspirin and Heparin Increase Bleeding Risk During EVT
New data from MR CLEAN-MED show that aspirin and heparin, alone or in combination, double the risk for symptomatic intracranial hemorrhage when given during endovascular therapy (EVT) for ischemic stroke.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 15, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

What's the Right TIMING for NOAC After Ischemic Stroke? What's the Right TIMING for NOAC After Ischemic Stroke?
Early treatment with novel oral anticoagulants is noninferior to delayed treatment among patients with ischemic stroke and atrial fibrillation, according to data from a registry-based randomized trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 14, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news

Mobile Stroke Units Linked to Reduced Stroke Disability Mobile Stroke Units Linked to Reduced Stroke Disability
In an observational study of patients with acute ischemic stroke, treatment in a mobile stroke unit was associated with better functional outcomes than treatment by emergency medical services.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 9, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

' No Reason to Drop tPA' in Stroke Thrombectomy: SWIFT DIRECT'No Reason to Drop tPA' in Stroke Thrombectomy: SWIFT DIRECT
A new study has failed to show noninferiority of direct thrombectomy compared to bridging therapy with thrombolysis before thrombectomy for patients with large-vessel occlusion ischemic stroke.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 2, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to Advancing Science for Genitourinary Cancers at AUA 2021
August 31, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. “Janssen maintains a strong commitment to advancing innovation and new therapeutic options for patients with genitourinary malignancies. As the treatment of genitourinary cancers becomes more complex, we continue to work with urologists and their teams to improve outcomes for patients across the continuum of disease...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

FDA OKs First Vagus Nerve Stimulation System for Stroke Rehab FDA OKs First Vagus Nerve Stimulation System for Stroke Rehab
The US Food and Drug Administration has approved a first-of-its kind vagus nerve stimulation system to treat moderate-to-severe upper extremity motor deficits associated with chronic ischemic stroke.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 27, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Regional Stroke Triage by EMS Ups Endovascular Therapy Rate
FRIDAY, Aug. 20, 2021 -- Implementation of a regional prehospital transport policy for comprehensive stroke center triage may result in a significant increase in endovascular therapy (EVT) rates among patients with acute ischemic stroke and large... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2021 Category: Pharmaceuticals Source Type: news

Women Less Likely to Get Best Care for Deadly Form of Stroke
FRIDAY, Aug. 6, 2021 -- Women are less likely than men to get the most effective treatment for a serious type of stroke, new research shows. Emergent large vessel occlusion (ELVO) is a type of ischemic stroke caused when blockages in large blood... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 6, 2021 Category: General Medicine Source Type: news

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study, The Lancet
The self-controlled case series (n=86,742) and matched cohort study (additional 348,481 control individuals) found Covid-19 was associated with increased risk of acute MI, highest during the first week, suggesting they represent a part of the clinical picture of Covid-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 2, 2021 Category: Consumer Health News Source Type: news

P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke
This review compared the effectiveness and safety of DAPT therapy with P2Y12 inhibitors and aspirin versus aspirin monotherapy in patients with mild ischemic stroke or high-risk TIA.Stroke (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 22, 2021 Category: Intensive Care Tags: Neurology & Neurosurgery Journal Article Source Type: news

Study shows aspirin can reduce the risk of heart attacks and strokes in patients with pneumonia
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research. (Source: University of Bristol news)
Source: University of Bristol news - July 7, 2021 Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Sex differences in post-stroke depression in the elderly - Mayman NA, Tuhrim S, Jett é N, Dhamoon MS, Stein LK.
OBJECTIVE: Post-stroke depression (PSD) occurs in approximately one-third of ischemic stroke patients. However, there is conflicting evidence on sex differences in PSD. We sought to assess sex differences in risk and time course of PSD in US ischemic strok... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Motor vehicle accident due to homonymous hemianopia: an unusual presentation of vertebrobasilar stroke - Al Rawahi A, Al Busaidi SA, Al Kalbani H, Al Alawi AM.
We present a case of a 57-year-old man who was brought to the emergency department after he sustained three minor motor vehicle ... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

More Clot Retrieval Attempts May Worsen Stroke Outcome
THURSDAY, June 24, 2021 -- For patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO), an increasing number of clot retrieval attempts (CRAs) is associated with unfavorable outcome, according to a study published online June 23... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Aidoc and Icometrix pair up for stroke care
Artificial intelligence (AI) software developer Aidoc has joined forces wit...Read more on AuntMinnie.comRelated Reading: Radiology Partners joins forces with Aidoc Aidoc unveils AI notification application for PE Icometrix launches AI software for ischemic stroke Aidoc and Imbio team up on AI for pulmonary embolism Icometrix names new chief commercial officer Icometrix nets FDA OK for epilepsy detection software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2021 Category: Radiology Source Type: news

Extended AF Monitoring Worth Considering After Eye Stroke Extended AF Monitoring Worth Considering After Eye Stroke
Patients with central retinal artery occlusion had a high rate of AF, comparable to that in patients with cerebral ischemic stroke, in a new study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 15, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Cardiac Monitor Implant Detects A-Fib in More Stroke Patients
WEDNESDAY, June 9, 2021 -- Among patients with ischemic stroke attributed to large- or small-vessel disease, an insertable cardiac monitor (ICM) more frequently detects atrial fibrillation (AF) over 12 months than usual care with external cardiac... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2021 Category: Pharmaceuticals Source Type: news

Improved detection of atrial fibrillation could prevent disabling strokes
(University of Alberta Faculty of Medicine& Dentistry) A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients -- one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period -- found the implantable device is more than three times more effective in detecting AF, and both are a significant improvement over the current standard of care in Alberta, Canada. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2021 Category: International Medicine & Public Health Source Type: news

OCD Linked to Increased Risk for Ischemic Stroke
Risk elevated during follow - up, especially for middle - aged and elderly adults, compared with non - OCD controls (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 28, 2021 Category: Psychiatry Tags: Cardiology, Neurology, Pharmacy, Psychiatry, Geriatrics, Journal, Source Type: news

OCD Linked to Increased Risk for Ischemic Stroke
FRIDAY, May 28, 2021 -- Adults with obsessive-compulsive disorder (OCD) have an increased risk for ischemic stroke, according to a study published online May 27 in Stroke. Mu-Hung Chen, M.D., Ph.D., from Taipei Veterans General Hospital in Taiwan,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 28, 2021 Category: Pharmaceuticals Source Type: news

Obsessive compulsive disorder linked to increased ischemic stroke risk later in life
(American Heart Association) Adults with obsessive-compulsive disorder (OCD) were more than three times as likely as those without the disorder to have an ischemic stroke later in life. Adults with OCD should maintain a healthy lifestyle, including not smoking, exercising, and managing a healthy weight, to help prevent stroke.Health care professionals should closely monitor patients with OCD for increased risk of ischemic stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 27, 2021 Category: International Medicine & Public Health Source Type: news

New AHA/ASA Guideline on Secondary Stroke Prevention New AHA/ASA Guideline on Secondary Stroke Prevention
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in an updated clinical practice guideline.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 25, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Risk of second stroke can be reduced with prevention efforts based on cause of first stroke
(American Heart Association) Having a stroke caused by blocked blood vessels or a transient ischemic attack (TIA) greatly increases your chances of having a future stroke. Identifying the cause or causes of the first stroke is key to developing strategies to prevent additional strokes.Managing blood pressure levels, reducing or quitting smoking, eating a healthy diet, and regular physical activity will reduce the risk of a second stroke, along with managing conditions such as Type 2 diabetes and high cholesterol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2021 Category: International Medicine & Public Health Source Type: news

New Class of Stentrievers for Acute Ischemic Stroke New Class of Stentrievers for Acute Ischemic Stroke
This study evaluated a novel operator-adjustable stent retriever, the Tigertriever. How did its effectiveness and safety in large-vessel occlusive stroke compare with established stent retrievers?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Hospitalizations for ischemic stroke before, during COVID-19 pandemic
(JAMA Network)What The Study Did:Hospital discharge rates, hospitalization outcomes and demographic factors were examined among U.S. patients with ischemic stroke before and during the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 17, 2021 Category: Infectious Diseases Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Racial Disparities in Endovascular Therapy for Stroke Persist Racial Disparities in Endovascular Therapy for Stroke Persist
Although the use of this beneficial treatment for ischemic stroke has increased in all racial and ethnic groups, Black and ethnic minority patients are still less likely to receive it.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 14, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

High BMI in Adolescence Linked to Ischemic Stroke in Adulthood
THURSDAY, May 13, 2021 -- High body mass index (BMI) in adolescence is associated with an increased risk for ischemic stroke in young adults, according to a study published online May 13 in Stroke. Aya Bardugo, M.D., from the Hebrew University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Recurrent Stroke'Alarmingly High' With Carotid Web Recurrent Stroke'Alarmingly High' With Carotid Web
Ischemic stroke patients with a carotid web – a protrusion in the carotid artery – have unacceptably high rates of recurrent stroke and may need more intensive secondary prevention, a new study suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 12, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Featured Review: Endovascular thrombectomy for acute ischaemic stroke
In thisrecently published Cochrane review, authors explored the effects of treating acute ischaemic stroke with endovascular thrombectomy and intra-arterial interventions.First author Melinda Roaldsen said: " This review of endovascular thrombectomy for acute ischaemic stroke strongly reinforces the efficacy and safety of endovascular interventions. Endovascular thrombectomy is a treatment modality in rapid development and continues to gain significance in acute stroke care. This review finds high evidence that endovascular thrombectomy improves functional and neurological outcomes without increasing intracerebral hae...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Featured Review: Endovascular thrombectomy and intra ‐arterial interventions for acute ischaemic stroke
In thisrecently published Cochrane review, authors explored the effects of treating acute ischaemic stroke with endovascular thrombectomy and intra-arterial interventions.First author Melinda Roaldsen said: " This review of endovascular thrombectomy for acute ischaemic stroke strongly reinforces the efficacy and safety of endovascular interventions. Endovascular thrombectomy is a treatment modality in rapid development and continues to gain significance in acute stroke care. This review finds high evidence that endovascular thrombectomy improves functional and neurological outcomes without increasing intracerebral hae...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Rehab + Vagus Nerve Stimulation May Restore Arm Function After Stroke
MONDAY, May 10, 2021 -- Patients with long-term loss of arm function after ischemic stroke have improvement in arm function following rehabilitation paired with vagus nerve stimulation (VNS), according to a study published in the April 24 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2021 Category: Pharmaceuticals Source Type: news

IAMs for Acute Ischemic Stroke During Mechanical Thrombectomy IAMs for Acute Ischemic Stroke During Mechanical Thrombectomy
This study investigated the role of intra-arterial adjunctive medications as rescue or concurrent therapy in combination with mechanical thrombectomy. Does it improve outcomes compared with MT alone?Stroke (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 28, 2021 Category: Radiology Tags: Neurology & Neurosurgery Journal Article Source Type: news

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche's introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could ...
Source: Roche Media News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche's introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could ...
Source: Roche Investor Update - April 28, 2021 Category: Pharmaceuticals Source Type: news

Acute ischemic stroke during convalescent phase of asymptomatic COVID-2019 infection in men
(JAMA Network)What The Study Did:This case series reports the risk factors, incidence rate and features of acute ischemic stroke experienced by a group of male patients ages 50 years or younger in the convalescent stage of COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 22, 2021 Category: Infectious Diseases Source Type: news

AAN: Stroke Occurs in 2.2 Percent of Patients Admitted to ICU With COVID - 19
Cumulative hazard of death increased in association with hemorrhagic stroke, but not with ischemic stroke (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 19, 2021 Category: Respiratory Medicine Tags: Infections, Neurology, Nursing, Pulmonology, Critical Care, Conference News, Source Type: news